Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Clinical trial NCT05581303 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05581303
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease

Start date: 2022-12-14
Primary completion: 2028-03-31
Enrollment: 7297

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.